Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
GAB2 |
GRB2-associated binding protein 2, transcript variant 2 |
FXC00100
|
FHC00100
|
FNC00100N
|
FNC00100C
|
GPRIN1 |
G protein regulated inducer of neurite outgrowth 1 |
FXC00296
|
FHC00296
|
FNC00296N
|
FNC00296C
|
ARHGEF7 |
Rho guanine nucleotide exchange factor (GEF) 7, transcript variant 1 |
FXC00426
|
FHC00426
|
FNC00426N
|
FNC00426C
|
RAPGEF5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
FXC00490
|
FHC00490
|
FNC00490N
|
FNC00490C
|
RNMT |
RNA (guanine-7-) methyltransferase, transcript variant 2 |
FXC00528
|
FHC00528
|
FNC00528N
|
FNC00528C
|
RASGRP3 |
RAS guanyl releasing protein 3 (calcium and DAG-regulated), transcript variant 3 |
FXC00656
|
FHC00656
|
FNC00656N
|
FNC00656C
|
SHOC2 |
SHOC2 leucine-rich repeat scaffold protein, transcript variant 1 |
FXC00664
|
FHC00664
|
FNC00664N
|
FNC00664C
|
PAK4 |
p21 protein (Cdc42/Rac)-activated kinase 4, transcript variant 5 |
FXC00749
|
FHC00749
|
FNC00749N
|
FNC00749C
|
PAK5 |
p21 (RAC1) activated kinase 5 (PAK5), transcript variant 1 |
FXC00788
|
FHC00788
|
FNC00788N
|
FNC00788C
|
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6, transcript variant 1 |
FXC01015
|
FHC01015
|
FNC01015N
|
FNC01015C
|
PLCE1 |
phospholipase C, epsilon 1, transcript variant 1 |
FXC01171
|
FHC01171
|
FNC01171N
|
FNC01171C
|
SYNGAP1 |
synaptic Ras GTPase activating protein 1 |
FXC01186
|
FHC01186
|
FNC01186N
|
FNC01186C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
PTPN11 |
protein tyrosine phosphatase, non-receptor type 11, transcript variant 1 |
FXC01231
|
FHC01231
|
FNC01231N
|
FNC01231C
|
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor), transcript variant 5 |
FXC01260
|
FHC01260
|
FNC01260N
|
FNC01260C
|
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
FXC01262
|
FHC01262
|
FNC01262N
|
FNC01262C
|
RASAL1 |
RAS protein activator like 1 (GAP1 like), transcript variant 2 |
FXC01273
|
FHC01273
|
FNC01273N
|
FNC01273C
|
MAPK9 |
mitogen-activated protein kinase 9, transcript variant JNK2-b2 |
FXC01315
|
FHC01315
|
FNC01315N
|
FNC01315C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
IGF1 |
insulin-like growth factor 1 (somatomedin C), transcript variant 4 |
FXC01347
|
FHC01347
|
FNC01347N
|
FNC01347C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
CALM3 |
calmodulin 3 (phosphorylase kinase, delta) |
FXC01403
|
FHC01403
|
FNC01403N
|
FNC01403C
|
ABL1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase, transcript variant b |
FXC01406
|
FHC01406
|
FNC01406N
|
FNC01406C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
PLA2G6 |
phospholipase A2, group VI (cytosolic, calcium-independent), transcript variant 1 |
FXC01421
|
FHC01421
|
FNC01421N
|
FNC01421C
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A, transcript variant 2 |
FXC01444
|
FHC01444
|
FNC01444N
|
FNC01444C
|
GRB2 |
growth factor receptor-bound protein 2, transcript variant 1 |
FXC01485
|
FHC01485
|
FNC01485N
|
FNC01485C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
RHOA |
ras homolog family member A |
FXC01522
|
FHC01522
|
FNC01522N
|
FNC01522C
|
IKBKG |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma, transcript variant 3 |
FXC01524
|
FHC01524
|
FNC01524N
|
FNC01524C
|
NCOA3 |
nuclear receptor coactivator 3, transcript variant 3 |
FXC01529
|
FHC01529
|
FNC01529N
|
FNC01529C
|
PLD1 |
phospholipase D1, phosphatidylcholine-specific, transcript variant 2 |
FXC01544
|
FHC01544
|
FNC01544N
|
FNC01544C
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
FXC01574
|
FHC01574
|
FNC01574N
|
FNC01574C
|
IGF1R |
insulin-like growth factor 1 receptor, transcript variant 2 |
FXC01578
|
FHC01578
|
FNC01578N
|
FNC01578C
|
RGL1 |
ral guanine nucleotide dissociation stimulator-like 1, transcript variant 4 |
FXC01616
|
FHC01616
|
FNC01616N
|
FNC01616C
|
PLCG1 |
phospholipase C, gamma 1, transcript variant 1 |
FXC01646
|
FHC01646
|
FNC01646N
|
FNC01646C
|
TEK |
TEK tyrosine kinase, endothelial, transcript variant 1 |
FXC01718
|
FHC01718
|
FNC01718N
|
FNC01718C
|
RASA3 |
RAS p21 protein activator 3 |
FXC01834
|
FHC01834
|
FNC01834N
|
FNC01834C
|
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, transcript variant 2 |
FXC01839
|
FHC01839
|
FNC01839N
|
FNC01839C
|
FLT1 |
fms-related tyrosine kinase 1, transcript variant 1 |
FXC01847
|
FHC01847
|
FNC01847N
|
FNC01847C
|
RASGRF1 |
Ras protein-specific guanine nucleotide-releasing factor 1, transcript variant 3 |
FXC01848
|
FHC01848
|
FNC01848N
|
FNC01848C
|
PRKCSH |
protein kinase C substrate 80K-H, transcript variant 2 |
FXC01870
|
FHC01870
|
FNC01870N
|
FNC01870C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
ANGPT1 |
angiopoietin 1, transcript variant 1 |
FXC01948
|
FHC01948
|
FNC01948N
|
FNC01948C
|
GNB1 |
guanine nucleotide binding protein (G protein), beta polypeptide 1, transcript variant 1 |
FXC02090
|
FHC02090
|
FNC02090N
|
FNC02090C
|
GNG4 |
guanine nucleotide binding protein (G protein), gamma 4, transcript variant 2 |
FXC02107
|
FHC02107
|
FNC02107N
|
FNC02107C
|
ARF6 |
ADP-ribosylation factor 6 |
FXC02124
|
FHC02124
|
FNC02124N
|
FNC02124C
|
KITLG |
KIT ligand, transcript variant b |
FXC02130
|
FHC02130
|
FNC02130N
|
FNC02130C
|
GNG10 |
guanine nucleotide binding protein (G protein), gamma 10, transcript variant 1 |
FXC02147
|
FHC02147
|
FNC02147N
|
FNC02147C
|
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1, transcript variant 1 |
FXC02157
|
FHC02157
|
FNC02157N
|
FNC02157C
|
GNG12 |
guanine nucleotide binding protein (G protein), gamma 12 |
FXC02211
|
FHC02211
|
FNC02211N
|
FNC02211C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
PLA2G2E |
phospholipase A2, group IIE |
FXC02329
|
FHC02329
|
FNC02329N
|
FNC02329C
|
PDGFA |
platelet-derived growth factor alpha polypeptide, transcript variant 2 |
FXC02363
|
FHC02363
|
FNC02363N
|
FNC02363C
|
SOS2 |
son of sevenless homolog 2 (Drosophila) |
FXC02373
|
FHC02373
|
FNC02373N
|
FNC02373C
|
SOS1 |
son of sevenless homolog 1 (Drosophila) |
FXC02380
|
FHC02380
|
FNC02380N
|
FNC02380C
|
KCNH4 |
potassium channel, voltage gated eag related subfamily H, member 4 |
FXC02382
|
FHC02382
|
FNC02382N
|
FNC02382C
|
EFNA2 |
ephrin-A2 |
FXC02434
|
FHC02434
|
FNC02434N
|
FNC02434C
|
RALA |
v-ral simian leukemia viral oncogene homolog A (ras related) |
FXC02618
|
FHC02618
|
FNC02618N
|
FNC02618C
|
BAD |
BCL2-associated agonist of cell death, transcript variant 1 |
FXC02680
|
FHC02680
|
FNC02680N
|
FNC02680C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
RAB5B |
RAB5B, member RAS oncogene family, transcript variant 1 |
FXC02758
|
FHC02758
|
FNC02758N
|
FNC02758C
|
PLA2G2A |
phospholipase A2, group IIA (platelets, synovial fluid), transcript variant 1 |
FXC02783
|
FHC02783
|
FNC02783N
|
FNC02783C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta, transcript variant 3 |
FXC02835
|
FHC02835
|
FNC02835N
|
FNC02835C
|
PLD2 |
phospholipase D2, transcript variant 1 |
FXC02836
|
FHC02836
|
FNC02836N
|
FNC02836C
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
FXC02856
|
FHC02856
|
FNC02856N
|
FNC02856C
|
RAP1B |
RAP1B, member of RAS oncogene family, transcript variant 1 |
FXC02891
|
FHC02891
|
FNC02891N
|
FNC02891C
|
BCL2L1 |
BCL2-like 1, transcript variant 1 |
FXC03091
|
FHC03091
|
FNC03091N
|
FNC03091C
|
MAPK10 |
mitogen-activated protein kinase 10, transcript variant 3 |
FXC03139
|
FHC03139
|
FNC03139N
|
FNC03139C
|
GNG7 |
guanine nucleotide binding protein (G protein), gamma 7 |
FXC03295
|
FHC03295
|
FNC03295N
|
FNC03295C
|
PLA1A |
phospholipase A1 member A, transcript variant 1 |
FXC03520
|
FHC03520
|
FNC03520N
|
FNC03520C
|
MAPK8 |
mitogen-activated protein kinase 8, transcript variant JNK1-b2 |
FXC03521
|
FHC03521
|
FNC03521N
|
FNC03521C
|
PRKCA |
protein kinase C, alpha |
FXC03611
|
FHC03611
|
FNC03611N
|
FNC03611C
|
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 1 |
FXC03635
|
FHC03635
|
FNC03635N
|
FNC03635C
|
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta, transcript variant 1 |
FXC03657
|
FHC03657
|
FNC03657N
|
FNC03657C
|
PRKCG |
protein kinase C, gamma |
FXC03659
|
FHC03659
|
FNC03659N
|
FNC03659C
|
CSF1 |
colony stimulating factor 1 (macrophage), transcript variant 1 |
FXC03695
|
FHC03695
|
FNC03695N
|
FNC03695C
|
ORC3 |
origin recognition complex, subunit 3, transcript variant 1 |
FXC03740
|
FHC03740
|
FNC03740N
|
FNC03740C
|
SHC1 |
SHC (Src homology 2 domain containing) transforming protein 1, transcript variant 3 |
FXC03742
|
FHC03742
|
FNC03742N
|
FNC03742C
|
PKN1 |
protein kinase N1, transcript variant 1 |
FXC03745
|
FHC03745
|
FNC03745N
|
FNC03745C
|
GAB1 |
GRB2-associated binding protein 1, transcript variant 1 |
FXC03750
|
FHC03750
|
FNC03750N
|
FNC03750C
|
PKN2 |
protein kinase N2 |
FXC03784
|
FHC03784
|
FNC03784N
|
FNC03784C
|
ZAP70 |
zeta-chain (TCR) associated protein kinase 70kDa, transcript variant 1 |
FXC03901
|
FHC03901
|
FNC03901N
|
FNC03901C
|
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent), transcript variant 1 |
FXC03961
|
FHC03961
|
FNC03961N
|
FNC03961C
|
ANGPT4 |
angiopoietin 4 |
FXC04100
|
FHC04100
|
FNC04100N
|
FNC04100C
|
C6orf89 |
chromosome 6 open reading frame 89, transcript variant 2 |
FXC04403
|
FHC04403
|
FNC04403N
|
FNC04403C
|
FGF5 |
fibroblast growth factor 5, transcript variant 1 |
FXC05019
|
FHC05019
|
FNC05019N
|
FNC05019C
|
FOXO4 |
forkhead box O4, transcript variant 1 |
FXC05227
|
FHC05227
|
FNC05227N
|
FNC05227C
|
GNG13 |
guanine nucleotide binding protein (G protein), gamma 13 |
FXC05319
|
FHC05319
|
FNC05319N
|
FNC05319C
|
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
FXC05358
|
FHC05358
|
FNC05358N
|
FNC05358C
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
FXC05918
|
FHC05918
|
FNC05918N
|
FNC05918C
|
GNG2 |
guanine nucleotide binding protein (G protein), gamma 2, transcript variant 2 |
FXC06059
|
FHC06059
|
FNC06059N
|
FNC06059C
|
PDGFB |
platelet-derived growth factor beta polypeptide, transcript variant 1 |
FXC06311
|
FHC06311
|
FNC06311N
|
FNC06311C
|
PLA2G1B |
phospholipase A2, group IB (pancreas) |
FXC06377
|
FHC06377
|
FNC06377N
|
FNC06377C
|
PLA2G2D |
phospholipase A2, group IID, transcript variant 1 |
FXC06378
|
FHC06378
|
FNC06378N
|
FNC06378C
|
PLA2G4D |
phospholipase A2, group IVD (cytosolic) |
FXC06382
|
FHC06382
|
FNC06382N
|
FNC06382C
|
PLA2G5 |
phospholipase A2, group V |
FXC06383
|
FHC06383
|
FNC06383N
|
FNC06383C
|
PRKACG |
protein kinase, cAMP-dependent, catalytic, gamma |
FXC06481
|
FHC06481
|
FNC06481N
|
FNC06481C
|
RAP1A |
RAP1A, member of RAS oncogene family, transcript variant 2 |
FXC06588
|
FHC06588
|
FNC06588N
|
FNC06588C
|
REL |
v-rel avian reticuloendotheliosis viral oncogene homolog, transcript variant 2 |
FXC06623
|
FHC06623
|
FNC06623N
|
FNC06623C
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A, transcript variant 1 |
FXC06624
|
FHC06624
|
FNC06624N
|
FNC06624C
|
GNB4 |
guanine nucleotide binding protein (G protein), beta polypeptide 4 |
FXC06872
|
FHC06872
|
FNC06872N
|
FNC06872C
|
NGF |
nerve growth factor (beta polypeptide) |
FXC07757
|
FHC07757
|
FNC07757N
|
FNC07757C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 2 |
FXC07774
|
FHC07774
|
FNC07774N
|
FNC07774C
|
PLA2G16 |
phospholipase A2, group XVI, transcript variant 1 |
FXC07990
|
FHC07990
|
FNC07990N
|
FNC07990C
|
PGF |
placental growth factor, transcript variant 1 |
FXC07993
|
FHC07993
|
FNC07993N
|
FNC07993C
|
GNB3 |
guanine nucleotide binding protein (G protein), beta polypeptide 3, transcript variant 1 |
FXC08063
|
FHC08063
|
FNC08063N
|
FNC08063C
|
INS |
insulin, transcript variant 1 |
FXC08231
|
FHC08231
|
FNC08231N
|
FNC08231C
|
ARHGAP9 |
Rho GTPase activating protein 9 |
FXC08262
|
FHC08262
|
FNC08262N
|
FNC08262C
|
FGF18 |
fibroblast growth factor 18 |
FXC08269
|
FHC08269
|
FNC08269N
|
FNC08269C
|
SPNS1 |
spinster homolog 1 (Drosophila), transcript variant 1 |
FXC08366
|
FHC08366
|
FNC08366N
|
FNC08366C
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
FXC08439
|
FHC08439
|
FNC08439N
|
FNC08439C
|
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
FXC08448
|
FHC08448
|
FNC08448N
|
FNC08448C
|
RALBP1 |
ralA binding protein 1 |
FXC08672
|
FHC08672
|
FNC08672N
|
FNC08672C
|
RIN1 |
Ras and Rab interactor 1 |
FXC08738
|
FHC08738
|
FNC08738N
|
FNC08738C
|
IL6 |
interleukin 6 |
FXC08788
|
FHC08788
|
FNC08788N
|
FNC08788C
|
FASLG |
Fas ligand (TNF superfamily, member 6), transcript variant 1 |
FXC08901
|
FHC08901
|
FNC08901N
|
FNC08901C
|
EFNA3 |
ephrin-A3 |
FXC08909
|
FHC08909
|
FNC08909N
|
FNC08909C
|
FGF12 |
fibroblast growth factor 12, transcript variant 2 |
FXC09106
|
FHC09106
|
FNC09106N
|
FNC09106C
|
GNGT1 |
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 |
FXC09285
|
FHC09285
|
FNC09285N
|
FNC09285C
|
CALML3 |
calmodulin-like 3 |
FXC09388
|
FHC09388
|
FNC09388N
|
FNC09388C
|
EFNA1 |
ephrin-A1, transcript variant 1 |
FXC09443
|
FHC09443
|
FNC09443N
|
FNC09443C
|
VEGFC |
vascular endothelial growth factor C |
FXC09559
|
FHC09559
|
FNC09559N
|
FNC09559C
|
EPHA2 |
EPH receptor A2 |
FXC09635
|
FHC09635
|
FNC09635N
|
FNC09635C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
VEGFB |
vascular endothelial growth factor B, transcript variant VEGFB-186 |
FXC09942
|
FHC09942
|
FNC09942N
|
FNC09942C
|
FGFR4 |
fibroblast growth factor receptor 4, transcript variant 1 |
FXC09979
|
FHC09979
|
FNC09979N
|
FNC09979C
|
FGF13 |
fibroblast growth factor 13, transcript variant 1 |
FXC09990
|
FHC09990
|
FNC09990N
|
FNC09990C
|
GNG3 |
guanine nucleotide binding protein (G protein), gamma 3 |
FXC10049
|
FHC10049
|
FNC10049N
|
FNC10049C
|
ETS2 |
v-ets avian erythroblastosis virus E26 oncogene homolog 2, transcript variant 1 |
FXC10074
|
FHC10074
|
FNC10074N
|
FNC10074C
|
FGF21 |
fibroblast growth factor 21 |
FXC10096
|
FHC10096
|
FNC10096N
|
FNC10096C
|
SHC3 |
SHC (Src homology 2 domain containing) transforming protein 3 |
FXC10206
|
FHC10206
|
FNC10206N
|
FNC10206C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
GNB2 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 |
FXC10441
|
FHC10441
|
FNC10441N
|
FNC10441C
|
FGFR3 |
fibroblast growth factor receptor 3
|
FXC10468
|
FHC10468
|
|
|
FGFR3 |
fibroblast growth factor receptor 3, transcript variant 1 |
FXC10478
|
FHC10478
|
FNC10478N
|
FNC10478C
|
CSF1R |
colony stimulating factor 1 receptor, transcript variant 1 |
FXC10479
|
FHC10479
|
FNC10479N
|
FNC10479C
|
RAB5A |
RAB5A, member RAS oncogene family, transcript variant 1 |
FXC10518
|
FHC10518
|
FNC10518N
|
FNC10518C
|
FGFR1 |
fibroblast growth factor receptor 1, transcript variant 3 |
FXC10532
|
FHC10532
|
FNC10532N
|
FNC10532C
|
PRKCB |
protein kinase C, beta, transcript variant 2 |
FXC10533
|
FHC10533
|
FNC10533N
|
FNC10533C
|
PRKACA |
protein kinase, cAMP-dependent, catalytic, alpha, transcript variant 1 |
FXC10564
|
FHC10564
|
FNC10564N
|
FNC10564C
|
RASSF1 |
Ras association (RalGDS/AF-6) domain family member 1, transcript variant A |
FXC10576
|
FHC10576
|
FNC10576N
|
FNC10576C
|
FGF1 |
fibroblast growth factor 1 (acidic), transcript variant 1 |
FXC10599
|
FHC10599
|
FNC10599N
|
FNC10599C
|
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2, transcript variant 1 |
FXC10622
|
FHC10622
|
FNC10622N
|
FNC10622C
|
RAB5C |
RAB5C, member RAS oncogene family, transcript variant 2 |
FXC10658
|
FHC10658
|
FNC10658N
|
FNC10658C
|
RRAS |
related RAS viral (r-ras) oncogene homolog |
FXC10666
|
FHC10666
|
FNC10666N
|
FNC10666C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
GNB5 |
guanine nucleotide binding protein (G protein), beta 5 |
FXC10771
|
FHC10771
|
FNC10771N
|
FNC10771C
|
PDGFB |
platelet-derived growth factor beta polypeptide |
FXC10772
|
FHC10772
|
FNC10772N
|
FNC10772C
|
FGF11 |
fibroblast growth factor 11, transcript variant 1 |
FXC10818
|
FHC10818
|
FNC10818N
|
FNC10818C
|
CHUK |
conserved helix-loop-helix ubiquitous kinase |
FXC10858
|
FHC10858
|
FNC10858N
|
FNC10858C
|
PLA2G2F |
phospholipase A2, group IIF |
FXC10921
|
FHC10921
|
FNC10921N
|
FNC10921C
|
MRAS |
muscle RAS oncogene homolog, transcript variant 1 |
FXC10922
|
FHC10922
|
FNC10922N
|
FNC10922C
|
STK4 |
serine/threonine kinase 4 |
FXC11122
|
FHC11122
|
FNC11122N
|
FNC11122C
|
INSR |
insulin receptor, transcript variant 2 |
FXC11132
|
FHC11132
|
FNC11132N
|
FNC11132C
|
RASAL2 |
RAS protein activator like 2, transcript variant 2 |
FXC11162
|
FHC11162
|
FNC11162N
|
FNC11162C
|
FGF16 |
fibroblast growth factor 16 |
FXC11178
|
FHC11178
|
FNC11178N
|
FNC11178C
|
ELK1 |
ELK1, member of ETS oncogene family, transcript variant 2 |
FXC11409
|
FHC11409
|
FNC11409N
|
FNC11409C
|
RASA2 |
RAS p21 protein activator 2, transcript variant 2 |
FXC11430
|
FHC11430
|
FNC11430N
|
FNC11430C
|
RASA4 |
RAS p21 protein activator 4, transcript variant 1 |
FXC11436
|
FHC11436
|
FNC11436N
|
FNC11436C
|
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
FXC11491
|
FHC11491
|
FNC11491N
|
FNC11491C
|
CDC42 |
cell division cycle 42, transcript variant 2 |
FXC11496
|
FHC11496
|
FNC11496N
|
FNC11496C
|
RASSF3 |
Ras association (RalGDS/AF-6) domain family member 3, transcript variant 1 |
FXC11728
|
FHC11728
|
FNC11728N
|
FNC11728C
|
FGF3 |
fibroblast growth factor 3 |
FXC11767
|
FHC11767
|
FNC11767N
|
FNC11767C
|
CALM2 |
calmodulin 2 (phosphorylase kinase, delta), transcript variant 2 |
FXC11793
|
FHC11793
|
FNC11793N
|
FNC11793C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 1 |
FXC11986
|
FHC11986
|
FNC11986N
|
FNC11986C
|
PAK3 |
p21 protein (Cdc42/Rac)-activated kinase 3, transcript variant 2 |
FXC12049
|
FHC12049
|
FNC12049N
|
FNC12049C
|
KSR2 |
kinase suppressor of ras 2 |
FXC12564
|
FHC12564
|
FNC12564N
|
FNC12564C
|
PDGFRA |
platelet derived growth factor receptor alpha |
FXC12575
|
FHC12575
|
FNC12575N
|
FNC12575C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
MET |
MET proto-oncogene, receptor tyrosine kinase, transcript variant 2 |
FXC12649
|
FHC12649
|
FNC12649N
|
FNC12649C
|
RASA4 |
RAS p21 protein activator 4, transcript variant 1 |
FXC12747
|
FHC12747
|
FNC12747N
|
FNC12747C
|
VEGFA |
vascular endothelial growth factor A, transcript variant 6 |
FXC13139
|
FHC13139
|
FNC13139N
|
FNC13139C
|
RASA1 |
RAS p21 protein activator (GTPase activating protein) 1, transcript variant 1 |
FXC13661
|
FHC13661
|
FNC13661N
|
FNC13661C
|
PAK2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
FXC16509
|
FHC16509
|
FNC16509N
|
FNC16509C
|
RALGDS |
ral guanine nucleotide dissociation stimulator, transcript variant 1 |
FXC16602
|
FHC16602
|
|
|
GNG5 |
guanine nucleotide binding protein (G protein), gamma 5 |
FXC20387
|
FHC20387
|
FNC20387N
|
FNC20387C
|
EFNA4 |
ephrin-A4, transcript variant 1 |
FXC20599
|
FHC20599
|
FNC20599N
|
FNC20599C
|
RALB |
v-ral simian leukemia viral oncogene homolog B |
FXC21157
|
FHC21157
|
FNC21157N
|
FNC21157C
|
KCNH8 |
potassium channel, voltage gated eag related subfamily H, member 8 |
FXC21449
|
FHC21449
|
FNC21449N
|
FNC21449C
|
KDR |
kinase insert domain receptor (a type III receptor tyrosine kinase) |
FXC21921
|
FHC21921
|
FNC21921N
|
FNC21921C
|
PDGFC |
platelet derived growth factor C, transcript variant 1 |
FXC22085
|
FHC22085
|
FNC22085N
|
FNC22085C
|
FGF10 |
fibroblast growth factor 10 |
FXC22164
|
FHC22164
|
FNC22164N
|
FNC22164C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
RGL2 |
ral guanine nucleotide dissociation stimulator-like 2, transcript variant 1 |
FXC22583
|
FHC22583
|
FNC22583N
|
FNC22583C
|
VEGFA |
vascular endothelial growth factor A
|
FXC22633
|
FHC22633
|
|
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
ANGPT2 |
angiopoietin 2, transcript variant 1 |
FXC23170
|
FHC23170
|
FNC23170N
|
FNC23170C
|
FGF20 |
fibroblast growth factor 20 |
FXC23199
|
FHC23199
|
FNC23199N
|
FNC23199C
|
FGF17 |
fibroblast growth factor 17, transcript variant 1 |
FXC23209
|
FHC23209
|
FNC23209N
|
FNC23209C
|
CALML5 |
calmodulin-like 5 |
FXC23748
|
FHC23748
|
FNC23748N
|
FNC23748C
|
FGFR2 |
fibroblast growth factor receptor 2, transcript variant 1 |
FXC24041
|
FHC24041
|
FNC24041N
|
FNC24041C
|
FGFR2 |
fibroblast growth factor receptor 2, transcript variant 9 |
FXC24045
|
FHC24045
|
|
|
FGF19 |
fibroblast growth factor 19 |
FXC24356
|
FHC24356
|
FNC24356N
|
FNC24356C
|
FGF4 |
fibroblast growth factor 4 |
FXC24357
|
FHC24357
|
FNC24357N
|
FNC24357C
|
FGF23 |
fibroblast growth factor 23
|
FXC24560
|
FHC24560
|
|
|
BRAP |
BRCA1 associated protein |
FXC24886
|
FHC24886
|
FNC24886N
|
FNC24886C
|
FGF9 |
fibroblast growth factor 9 |
FXC24958
|
FHC24958
|
FNC24958N
|
FNC24958C
|
FGF14 |
fibroblast growth factor 14, transcript variant 2 |
FXC25055
|
FHC25055
|
FNC25055N
|
FNC25055C
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|
SHC4 |
SHC (Src homology 2 domain containing) family, member 4 |
FXC25382
|
FHC25382
|
FNC25382N
|
FNC25382C
|
FGF7 |
fibroblast growth factor 7 |
FXC25383
|
FHC25383
|
FNC25383N
|
FNC25383C
|
GNGT2 |
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2, transcript variant 2 |
FXC26096
|
FHC26096
|
FNC26096N
|
FNC26096C
|
NGFR |
nerve growth factor receptor
|
FXC26099
|
FHC26099
|
|
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
GNG8 |
guanine nucleotide binding protein (G protein), gamma 8 |
FXC26701
|
FHC26701
|
FNC26701N
|
FNC26701C
|
TIAM1 |
T-cell lymphoma invasion and metastasis 1
|
FXC27150
|
FHC27150
|
|
|
FIGF |
c-fos induced growth factor (vascular endothelial growth factor D) |
FXC27307
|
FHC27307
|
FNC27307N
|
FNC27307C
|
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated), transcript variant 2 |
FXC28050
|
FHC28050
|
FNC28050N
|
FNC28050C
|
RASGRP4 |
RAS guanyl releasing protein 4, transcript variant a |
FXC30817
|
FHC30817
|
FNC30817N
|
FNC30817C
|
TBK1 |
TANK-binding kinase 1 |
FXC31490
|
FHC31490
|
FNC31490N
|
FNC31490C
|